Skip to main content
DIAN DIAGNOSTICS GROUP CO.,LTD. logo

DIAN DIAGNOSTICS GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 300244 ISIN · CNE1000015N1 LEI · 3003006MMJLCVIIKTA82 Shenzhen Stock Exchange Human health and social work activities
Open in API
Filings indexed 2,161 across all filing types
Latest filing 2026-05-07 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 300244

About DIAN DIAGNOSTICS GROUP CO.,LTD.

https://www.dazd.cn

DIAN Diagnostics Group Co., Ltd. is a comprehensive medical diagnostic service provider specializing in the independent clinical laboratory (ICL) sector. The company operates through an integrated "Service + Product" business model, offering a wide range of diagnostic services including clinical testing, pathology, forensic identification, and genomic testing. It manages an extensive network of diagnostic laboratories and provides outsourced testing services to medical institutions. In addition to laboratory services, the group distributes in vitro diagnostic (IVD) instruments and reagents from global and domestic manufacturers. Its technical capabilities span molecular diagnostics, mass spectrometry, and digital pathology, supporting precision medicine and public health initiatives. The company serves hospitals, community health centers, and research institutions, focusing on enhancing diagnostic efficiency and clinical decision-making through advanced technology.

Recent filings

Filing Released Lang Actions
关于参加浙江辖区上市公司2026年投资者网上集体接待日活动暨2025年度网上业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in an online investor meeting and performance explanation session for the 2025 fiscal year. It mentions the event date, participants, and topics to be discussed, including 2025 annual performance, governance, strategy, financing plans, and sustainability. The document does not contain actual financial statements or detailed financial data but rather informs investors about the upcoming event. The document length is short (583 characters), and it serves as a notice of an investor presentation event rather than the presentation or report itself. Therefore, the most appropriate classification is Investor Presentation (IP).
2026-05-07 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 85% confidence The document is an official corporate announcement detailing a change in accounting policies approved by the board, including reasons, implementation dates, and impacts. It is not a full financial report (10-K, IR, etc.), not a dividend notice, not an earnings release, and not a report publication notice. It is a standard regulatory disclosure of policy change, falling into the general regulatory filings category.
2026-04-21 Chinese
关于向金融机构申请授信额度及担保的公告
Capital/Financing Update Classification · 90% confidence The document is a formal public announcement by a listed company (证券代码: 300244) titled “关于向金融机构申请授信额度及担保的公告” (Announcement regarding applying for credit facilities and providing guarantees). It outlines the amounts of credit lines sought from various banks and the guarantee obligations the company and its subsidiaries will undertake. This falls squarely under capital/financing activities rather than a financial report, management change, legal notice, or other category. Therefore, it should be classified as a Capital/Financing Update (CAP).
2026-04-21 Chinese
关于2025年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an official stock exchange announcement by a listed company detailing its 2025 profit distribution proposal, including the cash dividend per share, total dividend amount, record basis after share repurchases, and related resolutions. This aligns with a Notice of Dividend Amount (DIV) rather than an annual report, earnings release, or other category. It is under 5,000 characters and specifically provides dividend details for shareholder information.
2026-04-21 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled "迪安诊断技术集团股份有限公司2025 年年度报告全文" which translates to "Dian Diagnostics Group Co., Ltd. 2025 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data for the full fiscal year 2025, management discussion and analysis, governance, and financial statements. The document length is substantial (15,000 characters), and it includes comprehensive financial figures, management commentary, and strategic outlook. There is no indication that this is merely an announcement or a summary; rather, it is the full annual report itself. Therefore, the document fits the definition of an Annual Report (10-K).
2026-04-21 Chinese
2025年年度审计报告
Audit Report / Information Classification · 96% confidence The document is titled “审计报告及财务报表” and contains the auditor’s opinion from BDO China along with the full set of financial statements (balance sheet, income statement, cash flow, equity changes, notes) for the period January 1 2025 to December 31 2025. It does not include broader annual report narrative or MD&A, but is a standalone audit report and accompanying financial statements. This fits the definition of an Audit Report / Information filing. FY 2025
2026-04-21 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.